Markets are rotating again.
Technology has been volatile, energy is swinging with geopolitics, and bond yields remain the quiet driver underneath equity pricing. In this environment, it makes sense to step outside crowded trades and revisit businesses with structural positioning rather than narrative momentum.
This week’s ASX Stocks in Focus avoids the names we’ve previously covered and instead looks at five companies with differentiated earnings drivers, pricing power, or structural tailwinds.
The focus isn’t short-term catalysts. It’s role-in-portfolio thinking.
ResMed (ASX: RMD)
Defensive Growth & AI Integration.
ResMed sits at the intersection of healthcare demand and digital health infrastructure. The company manufactures sleep apnoea devices and cloud-connected respiratory systems, with recurring revenue from masks and consumables.
The investment case has evolved over the past year.
Initial fears that weight-loss drugs (GLP-1 therapies) would reduce sleep apnoea prevalence caused a sell-off. But the reality is more nuanced. Obesity remains structurally high, diagnosis rates are still low globally, and adherence monitoring through digital platforms strengthens ResMed’s ecosystem moat.
What matters structurally:
- Recurring revenue model
- Software-enabled patient monitoring
- Ageing population tailwind
ResMed is not a hyper-growth name. It’s a durable compounder with global exposure and defensive earnings characteristics.
Portfolio role: Core healthcare allocation with resilient cash flow.
ALS Limited (ASX: ALQ)
Picks-and-Shovels Exposure to Resources & Environment.
ALS provides testing and inspection services across minerals, environmental, pharmaceutical and food sectors. It benefits from resource exploration cycles without taking commodity price risk directly.
When mining capex rises, ALS benefits. When environmental regulation tightens, ALS benefits. When pharmaceutical production expands, ALS benefits.
It’s an underappreciated compounder because it doesn’t sit cleanly in one thematic bucket.
Key structural drivers:
- Increased mineral exploration (critical minerals, copper, uranium)
- Environmental compliance standards
- Diversified geographic footprint
This is a lower-volatility way to gain exposure to resource cycles without owning miners directly.
Portfolio role: Defensive cyclical exposure.
TechnologyOne (ASX: TNE)
High-quality SaaS with Defensive Moat.
TechnologyOne has quietly become one of the most consistent software operators on the ASX. It focuses on enterprise resource planning (ERP) software for government and education sectors, clients that are sticky and long-dated.
Unlike high-beta SaaS names, its customer base is relatively insulated from discretionary spending shocks.
While broader tech volatility continues amid AI disruption fears, TechnologyOne’s subscription transition has strengthened margins and revenue visibility.
The key differentiator:
- High retention rates
- Mission-critical government contracts
- Gradual, disciplined expansion
It won’t deliver explosive returns overnight, but it rarely collapses either.
Portfolio role: Lower-beta tech exposure.
NEXTDC (ASX: NXT)
Infrastructure Behind the AI Boom.
While headline tech names swing on sentiment, the infrastructure powering AI continues expanding.
NEXTDC develops and operates data centres across Australia. Demand for colocation and hyperscale facilities continues rising as cloud adoption and AI workloads expand.
Unlike speculative AI software plays, data centres are tangible infrastructure assets with long-term contracts.
Risks remain:
- Capital intensity
- Power availability
- Interest rate sensitivity
But structurally, digital infrastructure remains a long-duration growth theme.
Portfolio role: Secular growth infrastructure exposure.
Read More
Final Thoughts
This week’s selection avoids crowded, high-volatility narratives and instead focuses on:
- Recurring revenue
- Structural tailwinds
- Asset-backed optionality
- Picks-and-shovels exposure
Markets remain sensitive to macro shocks and sector rotations. In that environment, clarity of earnings model and balance sheet strength matter more than thematic excitement.
The objective is not to chase momentum.
It’s to build allocation resilience.
Next week, we may lean more cyclically. But for now, quality and structure are in focus.